Your browser doesn't support javascript.
loading
Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
Murata, Shin-Ichi; Matsuzaki, Ibu; Kishimoto, Mitsuo; Katsuki, Naomi; Onishi, Toshinori; Hirokawa, Mitsuyoshi; Kojima, Fumiyoshi.
Afiliação
  • Murata SI; Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.
  • Matsuzaki I; Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.
  • Kishimoto M; Department of Surgical Pathology, Kyoto City Hospital, Kyoto, Japan.
  • Katsuki N; Department of Surgical Pathology, Kyoto City Hospital, Kyoto, Japan.
  • Onishi T; Department of Otorhinolaryngology, Kyoto City Hospital, Kyoto, Japan.
  • Hirokawa M; Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.
  • Kojima F; Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.
Pathol Int ; 73(5): 207-211, 2023 May.
Article em En | MEDLINE | ID: mdl-37042564
ABSTRACT
Papillary thyroid carcinoma (PTC) is usually indolent; however, some rare subtypes of PTCs, such as columnar cell and hobnail subtypes, carry poor prognosis as an intermediate malignancy between differentiated carcinoma and anaplastic carcinoma. We present the case of a 56-year-old Japanese woman having PTC with aggressive behavior showing characteristic histological features of a predominantly fused follicular and focally solid (FFS) pattern. The fused follicular pattern is cribriform-like without intermingled vessels. This PTC with FFS pattern included frequent mitotic figures, necrosis, lymphovascular invasion, and metastases with high clinical stage. The tumor cells were broadly positive for antibodies to TTF-1, PAX8, and bcl-2, and negative for cyclin D1. Ki-67 labeling index was approximately 10%, and there was occasional positivity of p53. Targeted next generation sequencing analysis only detected a NRAS mutation (Q61K); there was no mutation and no translocation of other genes including BRAF and RET/PTC. To our knowledge, this is first report that PTC shows aggressive FFS growth pattern. The tumor is possibly included in the new category of differentiated high-grade thyroid carcinoma in the World Health Organization 2022 classification, or in a novel subtype of PTC owing to its characteristic histological feature and intermediate malignancy between differentiated carcinoma and anaplastic carcinoma.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma / Carcinoma Papilar / Adenocarcinoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Pathol Int Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma / Carcinoma Papilar / Adenocarcinoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Pathol Int Ano de publicação: 2023 Tipo de documento: Article